Cargando…
Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133312/ https://www.ncbi.nlm.nih.gov/pubmed/34026767 http://dx.doi.org/10.3389/fcell.2021.696217 |
| _version_ | 1783695045995528192 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8133312 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81333122021-05-20 Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway Front Cell Dev Biol Cell and Developmental Biology Frontiers Media S.A. 2021-05-05 /pmc/articles/PMC8133312/ /pubmed/34026767 http://dx.doi.org/10.3389/fcell.2021.696217 Text en Copyright © 2021 Frontiers Editorial Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Cell and Developmental Biology Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway |
| title | Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway |
| title_full | Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway |
| title_fullStr | Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway |
| title_full_unstemmed | Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway |
| title_short | Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway |
| title_sort | retraction: parthenolide augments the chemosensitivity of non-small-cell lung cancer to cisplatin via the pi3k/akt signaling pathway |
| topic | Cell and Developmental Biology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133312/ https://www.ncbi.nlm.nih.gov/pubmed/34026767 http://dx.doi.org/10.3389/fcell.2021.696217 |
| work_keys_str_mv | AT retractionparthenolideaugmentsthechemosensitivityofnonsmallcelllungcancertocisplatinviathepi3kaktsignalingpathway |